Diagnostics Archives - Medicine Innovates

4-Amino-1, 8-naphthalimide-ferrocene conjugates as multi-targeted anticancer and fluorescent cellular imaging agents

4 weeks ago Diagnostics Comments Off on 4-Amino-1, 8-naphthalimide-ferrocene conjugates as multi-targeted anticancer and fluorescent cellular imaging agents

Facial emotion training as an intervention in autism spectrum disorder: A meta-analysis of randomized controlled trials

April 9, 2022 Diagnostics Comments Off on Facial emotion training as an intervention in autism spectrum disorder: A meta-analysis of randomized controlled trials

Algorithm detects early vascular disease using photos of the eye

February 16, 2022 Diagnostics Comments Off on Algorithm detects early vascular disease using photos of the eye

Repurposing PARP inhibitors for Cancer-Associated Sf3b1 Mutations

February 5, 2022 Diagnostics Comments Off on Repurposing PARP inhibitors for Cancer-Associated Sf3b1 Mutations

Detection of cancer through simultaneous detection of serotonin and dopamine

January 28, 2022 Diagnostics Comments Off on Detection of cancer through simultaneous detection of serotonin and dopamine

Trigging PCR test by Light Pulse

January 27, 2022 Diagnostics Comments Off on Trigging PCR test by Light Pulse

Metabolomics meets lipidomics: Assessing the small molecule component of metabolism

January 23, 2022 Diagnostics Comments Off on Metabolomics meets lipidomics: Assessing the small molecule component of metabolism

Carbon nanotube-based sensor developed as a rapid diagnostic for Covid-19 or other emerging pathogens

January 18, 2022 Diagnostics Comments Off on Carbon nanotube-based sensor developed as a rapid diagnostic for Covid-19 or other emerging pathogens

Evaluation of 99mTc-CN5DG as a broad-spectrum SPECT probe for tumor imaging

January 14, 2022 Diagnostics Comments Off on Evaluation of 99mTc-CN5DG as a broad-spectrum SPECT probe for tumor imaging

N-Acetylglucosamine: A new biomarker for severe Multiple Sclerosis

January 11, 2022 Diagnostics Comments Off on N-Acetylglucosamine: A new biomarker for severe Multiple Sclerosis